Printer Friendly

The Spectranetics Corporation appoints Scott Hutton as GM.

M2 EQUITYBITES-January 12, 2017-The Spectranetics Corporation appoints Scott Hutton as GM


The Spectranetics Corporation (NasdaqGS:SPNC), a provider of medical devices used in minimally invasive procedures within the cardiovascular system, revealed on Wednesday that it has appointed Scott Hutton as general manager of its vascular intervention.

Effective 23 January 2017, Hutton will report directly to the company's president and chief executive officer, Scott Drake.

Most recently, Hutton has served as the vice president and general manager of Medtronic's Neurosurgery business unit.

Previously, Hutton led Medtronic Navigation, a provider of integrated navigation and intra-operative imaging solutions, as well as held numerous global marketing and business development roles of increasing responsibility during his tenure at the company.

((Comments on this story may be sent to

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 12, 2017
Previous Article:Medovex Corporation signs international distribution agreement for DenerveX System in Italy.
Next Article:Skanska awarded USD40m contract to renovate high-rise building in Midtown Manhattan, New York.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters